Persistent pulmonary hypertension of the newborn

Mamta Fuloria, Judy L. Aschner

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Failure of the normal circulatory adaptation to extrauterine life results in persistent pulmonary hypertension of the newborn (PPHN). Although this condition is most often secondary to parenchymal lung disease or lung hypoplasia, it may also be idiopathic. PPHN is characterized by elevated pulmonary vascular resistance with resultant right-to-left shunting of blood and hypoxemia. Although the preliminary diagnosis of PPHN is often based on differential cyanosis and labile hypoxemia, the diagnosis is confirmed by echocardiography. Management strategies include optimal lung recruitment and use of surfactant in patients with parenchymal lung disease, maintaining optimal oxygenation and stable blood pressures, avoidance of respiratory and metabolic acidosis and alkalosis, and pulmonary vasodilator therapy. Extracorporeal membrane oxygenation is considered when medical management fails. Although mortality associated with PPHN has decreased significantly with improvements in medical care, there remains the potential risk for neurodevelopmental disability which warrants close follow-up of affected infants after discharge.

Original languageEnglish (US)
JournalSeminars in Fetal and Neonatal Medicine
DOIs
StateAccepted/In press - 2017

Fingerprint

Persistent Fetal Circulation Syndrome
Lung
Lung Diseases
Respiratory Alkalosis
Respiratory Acidosis
Extracorporeal Membrane Oxygenation
Cyanosis
Acidosis
Vasodilator Agents
Surface-Active Agents
Vascular Resistance
Echocardiography
Shock
Blood Pressure
Mortality

Keywords

  • Bosentan
  • Hypoxemia
  • Milrinone
  • Nitric oxide
  • Prostacyclin
  • Sildenafil

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Persistent pulmonary hypertension of the newborn. / Fuloria, Mamta; Aschner, Judy L.

In: Seminars in Fetal and Neonatal Medicine, 2017.

Research output: Contribution to journalArticle

@article{ad2326c6674946899e9221de707115e2,
title = "Persistent pulmonary hypertension of the newborn",
abstract = "Failure of the normal circulatory adaptation to extrauterine life results in persistent pulmonary hypertension of the newborn (PPHN). Although this condition is most often secondary to parenchymal lung disease or lung hypoplasia, it may also be idiopathic. PPHN is characterized by elevated pulmonary vascular resistance with resultant right-to-left shunting of blood and hypoxemia. Although the preliminary diagnosis of PPHN is often based on differential cyanosis and labile hypoxemia, the diagnosis is confirmed by echocardiography. Management strategies include optimal lung recruitment and use of surfactant in patients with parenchymal lung disease, maintaining optimal oxygenation and stable blood pressures, avoidance of respiratory and metabolic acidosis and alkalosis, and pulmonary vasodilator therapy. Extracorporeal membrane oxygenation is considered when medical management fails. Although mortality associated with PPHN has decreased significantly with improvements in medical care, there remains the potential risk for neurodevelopmental disability which warrants close follow-up of affected infants after discharge.",
keywords = "Bosentan, Hypoxemia, Milrinone, Nitric oxide, Prostacyclin, Sildenafil",
author = "Mamta Fuloria and Aschner, {Judy L.}",
year = "2017",
doi = "10.1016/j.siny.2017.03.004",
language = "English (US)",
journal = "Nature Methods",
issn = "1548-7091",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Persistent pulmonary hypertension of the newborn

AU - Fuloria, Mamta

AU - Aschner, Judy L.

PY - 2017

Y1 - 2017

N2 - Failure of the normal circulatory adaptation to extrauterine life results in persistent pulmonary hypertension of the newborn (PPHN). Although this condition is most often secondary to parenchymal lung disease or lung hypoplasia, it may also be idiopathic. PPHN is characterized by elevated pulmonary vascular resistance with resultant right-to-left shunting of blood and hypoxemia. Although the preliminary diagnosis of PPHN is often based on differential cyanosis and labile hypoxemia, the diagnosis is confirmed by echocardiography. Management strategies include optimal lung recruitment and use of surfactant in patients with parenchymal lung disease, maintaining optimal oxygenation and stable blood pressures, avoidance of respiratory and metabolic acidosis and alkalosis, and pulmonary vasodilator therapy. Extracorporeal membrane oxygenation is considered when medical management fails. Although mortality associated with PPHN has decreased significantly with improvements in medical care, there remains the potential risk for neurodevelopmental disability which warrants close follow-up of affected infants after discharge.

AB - Failure of the normal circulatory adaptation to extrauterine life results in persistent pulmonary hypertension of the newborn (PPHN). Although this condition is most often secondary to parenchymal lung disease or lung hypoplasia, it may also be idiopathic. PPHN is characterized by elevated pulmonary vascular resistance with resultant right-to-left shunting of blood and hypoxemia. Although the preliminary diagnosis of PPHN is often based on differential cyanosis and labile hypoxemia, the diagnosis is confirmed by echocardiography. Management strategies include optimal lung recruitment and use of surfactant in patients with parenchymal lung disease, maintaining optimal oxygenation and stable blood pressures, avoidance of respiratory and metabolic acidosis and alkalosis, and pulmonary vasodilator therapy. Extracorporeal membrane oxygenation is considered when medical management fails. Although mortality associated with PPHN has decreased significantly with improvements in medical care, there remains the potential risk for neurodevelopmental disability which warrants close follow-up of affected infants after discharge.

KW - Bosentan

KW - Hypoxemia

KW - Milrinone

KW - Nitric oxide

KW - Prostacyclin

KW - Sildenafil

UR - http://www.scopus.com/inward/record.url?scp=85016055873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016055873&partnerID=8YFLogxK

U2 - 10.1016/j.siny.2017.03.004

DO - 10.1016/j.siny.2017.03.004

M3 - Article

C2 - 28342684

AN - SCOPUS:85016055873

JO - Nature Methods

JF - Nature Methods

SN - 1548-7091

ER -